viernes, 8 de marzo de 2019

Cystic Fibrosis News Today Weekly Digest


Cystic Fibrosis Weekly Update

Contents:

Positive Data from VX-445 Triple Combo Regimen Prompt Vertex to Seek Regulatory Approval

Mar 08, 2019 07:00 am | Alice Melão



VX-445 AURORA VertexVertex Pharmaceuticals is planning to request regulatory approval from the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) during the third and fourth quarters of 2019, respectively, for VX-659 or VX-445 triple combination regimens. If approved, these new combo therapies will represent an alternative and effective strategy to treat cystic fibrosis (CF) […]
The post Positive Data from VX-445 Triple Combo Regimen Prompt Vertex to Seek Regulatory Approval appeared first on Cystic Fibrosis News Today.
Read More
share on TwitterLike Positive Data from VX-445 Triple Combo Regimen Prompt Vertex to Seek Regulatory Approval on Facebook

Window for More Effective Treatment of CF Lung Infections is 2 to 3 Years, Study Suggests

Mar 07, 2019 11:30 am | Jose Marques Lopes, PhD



treatment of lung infectionsTreatment of Pseudomonas aeruginosa lung infections in cystic fibrosis (CF) patients could be more effective if done within a crucial two- to three-year period when the bacteria are still susceptible to antibiotics, according to a study. The study, “Evolutionary highways to persistent bacterial infection,” was published in the journal Nature Communications. Genetic changes that have accumulated over […]
The post Window for More Effective Treatment of CF Lung Infections is 2 to 3 Years, Study Suggests appeared first on Cystic Fibrosis News Today.
Read More
share on TwitterLike Window for More Effective Treatment of CF Lung Infections is 2 to 3 Years, Study Suggests on Facebook

How Does Cystic Fibrosis Affect Our Fear of Failure?

Mar 07, 2019 09:00 am | Elly Aylwin-Foster



failureI was made redundant last year. A week later, I turned 30. One week after that, I found out that I had failed to make it into the preliminary stages of the first publishing competition I’d entered. Then the following week, I was admitted to hospital with one hell of a cystic fibrosis (CF) exacerbation. […]
The post How Does Cystic Fibrosis Affect Our Fear of Failure? appeared first on Cystic Fibrosis News Today.
Read More
share on TwitterLike How Does Cystic Fibrosis Affect Our Fear of Failure? on Facebook

NIH Rare Disease Day Highlights Joint Networks Advancing Array of Research

Mar 07, 2019 07:00 am | Susan Boswell



NIHRare diseases affect about 30 million Americans — roughly the same number as those with type 2 diabetes. Yet only 5 percent of the estimated 7,000 rare diseases known to science have cures or treatments approved by the U.S. Food and Drug Administration (FDA). Raising awareness of those illnesses and highlighting the promise of new therapies […]
The post NIH Rare Disease Day Highlights Joint Networks Advancing Array of Researchappeared first on Cystic Fibrosis News Today.
Read More
share on TwitterLike NIH Rare Disease Day Highlights Joint Networks Advancing Array of Research on Facebook
 

Recent News

Translate Bio Advancing MRT5005 Through Ongoing Phase 1/2 Trial in CF Patients
MaRS Innovation Supports LAB150 Research on New Therapeutics for CF and Other Conditions
Don’t Distance Yourself from Your OG Carers
The Power of Escapism
European HIT-CF Project to Explore ELX-02 as Treatment for Rare CF Mutations

No hay comentarios:

Publicar un comentario